ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

24,557Medicare Part D Prescriptions Filled, Including Refills

Rank: 28 out of 1000

$1.15M Total Retail Price of All Prescriptions

Rank: 28 out of 1000

793 Patients Receiving at Least One Drug in Part D
54%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 793 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

42% of this provider’s 793 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

3% of this provider’s 15,828 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 2,306 1,026 S3 1 1
OMEPRAZOLE 926 542 2 2
LEVOTHYROXINE SODIUM 675 517 3 4
POTASSIUM CHLORIDE 662 521 4 10
SIMVASTATIN 605 381 5 3
LISINOPRIL 552 351 6 5
FUROSEMIDE 542 456 7 7
AMLODIPINE BESYLATE 404 253 8 6
TRAMADOL HCL 403 198 9 13
METFORMIN HCL 378 235 10 8
WARFARIN SODIUM 364 242 11 22
MIRTAZAPINE 336 287 12 56
MELOXICAM 287 183 13 14
GABAPENTIN 259 157 14 11
METOPROLOL TARTRATE 254 132 15 19
NIFEDIPINE ER 247 148 16 130
NEXIUM 243 132 17 23
GLIPIZIDE 242 171 18 62
PANTOPRAZOLE SODIUM 241 202 19 28
NAMENDA 229 229 20 43
DONEPEZIL HCL 228 216 21 32
DIVALPROEX SODIUM 208 165 22 113
FLUOXETINE HCL 205 106 23 51
CLONIDINE HCL 204 103 24 27
TRAZODONE HCL 202 124 25 29
HYDROCHLOROTHIAZIDE 195 91 26 9
TIZANIDINE HCL 187 61 27 76
ZOLPIDEM TARTRATE 185 98 28 16
BUMETANIDE 184 141 29 112
CITALOPRAM HBR 181 110 30 17
HYDRALAZINE HCL 178 136 31 74
SERTRALINE HCL 178 153 31 26
SPIRONOLACTONE 174 132 33 78
CARVEDILOL 168 114 34 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 164 58 35 20
CYCLOBENZAPRINE HCL 156 41 R 36 39
KLOR-CON M20 149 96 37 66
ESCITALOPRAM OXALATE 145 99 38 60
METOPROLOL SUCCINATE 139 100 39 21
PREDNISONE 137 80 40 42
PRAVASTATIN SODIUM 136 98 41 12
CYMBALTA 123 93 42 53
NITROGLYCERIN PATCH 122 102 43 226
DIGOXIN 118 106 44 52
PROMETHAZINE HCL 115 62 R 45 54
SULFAMETHOXAZOLE-TRIMETHOPRIM 114 76 46 70
SPIRIVA 111 61 47 64
EXELON 111 110 47 108
CRESTOR 111 53 47 30
TAMSULOSIN HCL 111 106 47 33
RANITIDINE HCL 107 76 51 37
PHENYTOIN SODIUM EXTENDED 107 62 51 115
LYRICA 106 65 53 47
ENDOCET 104 29 S2 54 107
HUMULIN 70-30 104 75 54 131
IBUPROFEN 103 35 56 94
ALENDRONATE SODIUM 101 83 57 57
VENTOLIN HFA 100 54 58 83
AZITHROMYCIN 99 58 59 36
LEVETIRACETAM 99 39 59 128
ATORVASTATIN CALCIUM 97 70 61 18
PROAIR HFA 94 26 62 50
LOVASTATIN 93 74 63 41
ISOSORBIDE MONONITRATE ER 90 84 64 71
METOCLOPRAMIDE HCL 88 62 65 99
PRAMIPEXOLE DIHYDROCHLORIDE 87 59 66 147
RISPERIDONE 87 69 66 87
FLUTICASONE PROPIONATE 85 45 68 40
LEVOFLOXACIN 85 70 68 73
DIOVAN 83 45 70 67
OXYBUTYNIN CHLORIDE 83 79 70 145
NOVOLOG FLEXPEN 82 57 72 267
CLOPIDOGREL 81 60 73 35
METHOCARBAMOL 81 39 R 73 79
LOSARTAN POTASSIUM 80 43 75 25
LANTUS SOLOSTAR 77 52 76 120
HYDROXYZINE HCL 76 53 R 77 153
VERAPAMIL ER 75 63 78 86
MECLIZINE HCL 75 61 78 80
FLUCONAZOLE 71 24 80 102
ENALAPRIL MALEATE 71 45 80 58
LANTUS 71 59 80 68
BENZTROPINE MESYLATE 69 54 R 83 180
ALLOPURINOL 69 45 83 31
INSULIN SYRINGE 68 30 85 93
VALPROIC ACID 68 55 85 233
NITROFURANTOIN 67 54 87 199
AMITRIPTYLINE HCL 66 18 R 88 45
CELEBREX 66 56 88 98
ATENOLOL 66 47 88 24
SINGULAIR 66 28 88 84
LOSARTAN-HYDROCHLOROTHIAZIDE 65 39 92 38
NOVOFINE AUTOCOVER 65 48 92 404
CIPROFLOXACIN HCL 64 49 94 46
DOXYCYCLINE HYCLATE 62 36 95 97
PREMARIN 62 14 R 95 109
QUETIAPINE FUMARATE 61 25 97 75
CARISOPRODOL 61 0 R 97 72
AMLODIPINE BESYLATE-BENAZEPRIL 61 61 97 59
PLAVIX 61 56 97 49
BUSPIRONE HCL 60 57 101 110
PAROXETINE HCL 60 42 101 63
RESTASIS 59 50 103 272
LEXAPRO 59 50 103 196
NOVOLOG 57 47 105 156
AMOXICILLIN 57 23 105 89
FAMOTIDINE 56 47 107 88
GEMFIBROZIL 55 39 108 105
GEODON 55 46 108 339
OXYCONTIN 55 38 S2 108 166
MUPIROCIN 54 37 111 140
NIFEDIAC CC 53 46 112 345
MONTELUKAST SODIUM 53 19 112 132
ABILIFY 52 16 114 198
ALBUTEROL SULFATE 52 50 114 142
FENTANYL 52 44 S2 114 100
SUCRALFATE 50 40 117 144
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.